The risk of cardiovascular events associated with inhaled long-acting beta-2-adrenoreceptor agonists in patients with chronic obstructive pulmonary disease

被引：1
|
作者：
Ogale, Sarika S. [1 ]
Lee, Todd A. [1 ]
Sullivan, Sean D. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
CHEST | 2006年 / 130卷 / 04期
关键词：
D O I：
10.1378/chest.130.4_MeetingAbstracts.121S-d
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：121S / 122S
页数：2
相关论文
共 50 条
  • [1] Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease
    van Geffen, Wouter H.
    Tan, Daniel J.
    Walters, Julia A. E.
    Walters, E. Haydn
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (12):
  • [2] Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease
    Tan, Daniel J.
    White, Clinton J.
    Walters, Julia A. E.
    Walters, E. Haydn
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (11):
  • [3] Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease
    Spencer, Sally
    Karner, Charlotta
    Cates, Christopher J.
    Evans, David J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [4] Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease
    Spencer, Sally
    Evans, David J.
    Karner, Charlotta
    Cates, Christopher J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (10):
  • [5] COMPARISON OF THREE COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONISTS WITH LONG-ACTING BETA AGONISTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Mochizuki, Taichi
    Inoue, Yasushi
    Ueda, Ryuta
    Nagase, Seisuke
    Iwasaki, Kentarou
    Kojika, Masakazu
    Hayashi, Aeru
    RESPIROLOGY, 2018, 23 : 247 - 247
  • [6] Long-acting beta2-agonists for chronic obstructive pulmonary disease
    Kew, Kayleigh M.
    Mavergames, Chris
    Walters, Julia A. E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (10):
  • [7] Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease
    Wang, Meng-Ting
    Lai, Jyun-Heng
    Tsai, Chen-Liang
    Liou, Jun-Ting
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2019, 27 (03) : 657 - 670
  • [8] Theophyllines, long-acting ß2-agonists and inhaled corticosteroids and the risk of mortality among patients with chronic obstructive pulmonary disease
    Cyr, Marie-Christyne
    Beauchesne, Marie-France
    Lemière, Catherine
    Blais, Lucie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S9 - S9
  • [9] Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population
    Tsai, Ming-Jun
    Chen, Chung-Yu
    Huang, Yaw-Bin
    Chao, Hsiao-Chung
    Yang, Chih-Jen
    Lin, Pei-Jin
    Tsai, Yi-Hung
    MEDICINE, 2015, 94 (51)
  • [10] The effect of adding inhaled corticosteroids to tiotropium and long-acting beta2-agonists for chronic obstructive pulmonary disease
    Karner, Charlotta
    Cates, Christopher J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (09):
12345